Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: A French intergroup study

Journal of Clinical Oncology

Volumn 15, Issue 2, 1997, Pages 808-815

  de Gramont, A ^a   Bosset, J F ^a   Milan, C ^a   Rougier, P ^a   Bouche O ^a   Etienne, P L ^a   Morvan, F ^a   Louvet, C ^a   Guillot, T ^a   Francois E ^a   Bedenne, L ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SURVIVAL TIME;

EID: 0031019918     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.2.808     Document Type: Article

References (30)

1. Pinedo HM, Peters GFJ: Fluorouracil: Biochemistry and pharmacology. J Clin Oncol 6:1653-1664, 1988
2. Matsuoka H, Ueo H, Sugimachi K, et al.: Preliminary evidence that incorporation of 5-fluorouracil into RNA correlates with antitumor response. Cancer Invest 10:265-269, 1992
3. Machover D, Goldschmidt E, Chollet P, et al.: Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid. J Clin Oncol 4:685-696, 1986
4. Petrelli N, Herrera L, Rustum Y, et al.: A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma. J Clin Oncol 5:1559-1565, 1987
5. Advanced Colorectal Cancer Meta-Analysis Project: Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rate. J Clin Oncol 10:896-903, 1992
6. Petrelli N, Douglass HO, Herrera L, et al.: The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: A prospective randomized phase III trial. J Clin Oncol 7:1419-1426, 1989
7. Poon MA, O'Connell MJ, Moertel CG, et al.: Biochemical modulation of fluorouracil: Evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. J Clin Oncol 7:1407-1418, 1989
8. Poon MA, O'Connell MJ, Wieand HS, et al.: Biochemical modulation of fluorouracil with leucovorin: Confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer. J Clin Oncol 9:1967-1972, 1991
9. Buroker TR, O'Connell MJ, Wieand S, et al.: Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer. J Clin Oncol 12:14-20, 1994
10. Lokich JJ, Ahlgren JD, Gullo JJ, et al.: A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: A Mid-Atlantic Oncology Program study. J Clin Oncol 7:425-432, 1989
11. Rougier Ph, Paillot B, Laplanche A, et al.: End results of a multicentric randomized trial comparing 5-FU in continuous infusion to bolus administration in measurable metastatic colorectal cancer. Proc Am Soc Clin Oncol 11:163, 1992 (abstr 465)
12. Budd GT, Fleming TR, Bukowski JD, et al.: 5 Fluorouracil and folinic acid in the treatment of metastatic colorectal cancer: A randomized comparison. A Southwest Oncology Group study. J Clin Oncol 5:272-277, 1987
13. Leichman CG, Fleming TR, Muggia FM, et al.: Phase II study of fluorouracil and its modulation in advanced colorectal cancer: A Southwest Oncology Group study. J Clin Oncol 13:1303-1311, 1995
14. de Gramont A, Krulik M, Cady J, et al.: High-dose folinic acid and 5-fluorouracil bolus and continuous infusion in advanced colorectal cancer. Eur J Cancer Oncol 24:1499-1503, 1988
15. Johnson PWM, Thompson PI, Seymour MT, et al.: A less toxic regimen of 5-fluorouracil and high-dose folinic acid for advanced gastrointestinal adenocarcinomas. Br J Cancer 64:603-605, 1991
16. Becouarn Y, Cany L, Rouhier ML, et al.: High-dose folinic acid and 5-fluorouracil bolus and continuous infusion in advanced colorectal cancer. Proc Am Soc Clin Oncol 13:204, 1994 (abstr 604)
17. Sobrero AF, Aschele C, Guglielmi AP, et al.: Synergism and lack of cross-resistance between short-term and continuous exposure to fluorouracil in human colon adenocarcinoma cells. J Natl Cancer Inst 85:1937-1944, 1993
18. Mantel N, Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748, 1959
19. Kaplan EL, Meier P: Non parametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
20. Cox DR: Regression models and life-tables. J R Stat Soc 348:187-220, 1972
21. Dixon WJ: BMDP Statistical Software. Berkeley, CA, University of California Press, 1992
22. Borner M, Brand B, Lang M, et al.: Low-dose leucovorin significantly changes the effect of fluorouracil: Results of a randomized pilot study in advanced colorectal carcinoma. Proc Am Soc Clin Oncol 11:183, 1992 (abstr 546)
23. Scheithauer W, Depisch D, Kornek G, et al.: Randomized comparison of fluorouracil and leucovorin therapy versus fluorouracil, leucovorin and cisplatin therapy in patients with advanced colorectal cancer. Cancer 73:1562-1568, 1994
24. Valsecchi R, Labianca R, Cascinu S, et al.: High-dose versus low-dose 1-leucovorin as a modulator of 5-days 5-fluorouracil in advanced colorectal cancer: A GISCAD phase III study. Proc Am Soc Clin Oncol 14:195, 1995 (abstr 457)
25. Seitz JF, Cunnigham D, Rath U, et al.: Final results and survival data of a large randomized trial of tomudex in advanced colorectal cancer confirm comparable efficacy to 5-fluorouracil plus leucovorin. Proc Am Soc Clin Oncol 15:201, 1996 (abstr 446)
26. Conroy T, Adenis A, Brucker P, et al.: A prospective randomized trial of protracted infusional 5FU with allopurinol versus bolus and high-dose leucovorin in metastatic colorectal cancers. Proc Am Soc Clin Oncol 11:162, 1992 (abstr 462)
27. Mon A, Bertoglio S, Guglielmi A, et al.: Activity of continuous-infusion 5-fluorouracil in patients with advanced colorectal cancer clinically resistant to bolus 5-fluorouracil. Cancer Chemother Pharmacol 33:179-180, 1993
28. Seymour MT, Slevin M, Kerr DJ, et al.: Randomized trial assessing the addition of interferon α-2a to fluorouracil and leucovorin in advanced colorectal cancer. J Clin Oncol 14:2280-2288, 1996
29. Louvet C, de Gramont A, Bennamoun M, et al.: Sequential cisplatin, high-dose folinic acid, 5FU bolus and infusion in advanced gastric cancer. Proc Am Soc Clin Oncol 11:178, 1992 (abstr 528)
30. de Gramont A, Louvet C, Bennamoun M, et al.: Dual modulation of 5-fluorouracil with folinic acid and hydroxyurea in metastatic colorectal cancer. J Infusional Chemother 6:97-101, 1996